Quarterly Result21 May 2026, 08:11 pm
iSERA Lifesciences Approves FY26 Financial Results
AI Summary
iSERA Lifesciences Limited (formerly Covidh Technologies Limited) announced the approval of its audited financial results for the year ended March 31, 2026, during a board meeting held on May 21, 2026. The board also approved the Independent Auditor’s Report and a declaration for unmodified opinion on the financial results.
Key Highlights
- Audited financial results (standalone) for FY26 approved.
- Independent Auditor’s Report on FY26 results approved.
- Declaration for unmodified opinion issued for FY26 results.
- Board meeting held via video conference on May 21, 2026.
Price Impact
More from COVIDH